A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of VSA003 in Chinese HoFH Patients

Clinical trial NCT06712771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06712771
Sponsor: Visirna Therapeutics HK Limited
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia (HoFH)

Start date: 2024-11-27
Primary completion: 2025-12-31
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.